Back to results
US 2007/0191345 A1Published application
3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
AssigneeGlaxo Group Limited
InventorsMahmood Ahmed, Christopher Johnson, Neil Miller, Giancarlo Trani, David Witty
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel quinoline derivatives such as compounds of the formula (I): and the use of such compounds or pharmaceutical compositions thereof in the treatment of CNS and other disorders.
Claims10
A compound of formula (I) or a pharmaceutically acceptable salt thereof:
- wherein:
- R1 represents a group of formula —NRaRb or a nitrogen containing heterocyclyl group optionally substituted by one or more (eg. 1 to 4) C1-6 alkyl groups;
- X represents a bond, —(CRcRd)—, —(CRcRd)—(CReRf)—, —(CRcRd)—(CReRf)—(CRgRh)—, or -heterocyclyl-, wherein said heterocyclyl group may be optionally substituted by one or more (eg. 1 to 4) C1-6 alkyl groups;
- such that when R1 represents —NRaRb, X does not represent a bond nor —(CRcRd)—;
- Ra, Rb, Rc, Rd, Re, Rf, Rg and Rh independently represent hydrogen or C1-6 alkyl;
- R2 represents halogen, cyano, —CF3, —CF3O, C1-6 alkyl, C1-6 alkoxy, C1-6 alkanoyl or a group —CONR5R6;
- n represents 0 to 3;
- R3 and R4 independently represent hydrogen, halogen, cyano, —CF3, —CF3O, C1-6 alkyl, C1-6 alkoxy, C1-6 alkanoyl or a group —CONR5R6;
- R5 and R6 independently represent hydrogen or C1-6 alkyl or together with the N atom to which they are attached may be fused to form a 5- to 7- membered N-containing aromatic or non-aromatic heterocyclic ring optionally interrupted by an O or S atom;
- A represents an -aryl, -heteroaryl, -aryl-aryl, -aryl-heteroaryl, -heteroaryl-aryl or -heteroaryl-heteroaryl group;
- wherein said aryl and heteroaryl groups of A may be optionally substituted by one or more (eg. 1, 2 or 3) substituents which may be the same or different, and which are selected from the group consisting of halogen, hydroxy, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-6 alkyl, trifluoromethanesulfonyloxy, pentafluoroethyl, C1-6 alkoxy, arylC1-6 alkoxy, C1-6 alkylthio, C1-6 alkoxyC1-6 alkyl, C3-7 cycloalkylC1-6 alkoxy, C1-6 alkanoyl, C1-6 alkoxycarbonyl, C1-6 alkylsulfonyl, C1-6 alkylsulfinyl, C1-6 alkylsulfonyloxy, C1-6 alkylsulfonylC1-6 alkyl, arylsulfonyl, arylsulfonyloxy, arylsulfonylC1-6 alkyl, C1-6 alkylsulfonamido, C1-6 alkylamido, C1-6 alkylsulfonamidoC1-6 alkyl, C1-6 alkylamidoC1-6 alkyl, arylsulfonamido, arylcarboxamido, arylsulfonamidoC1-6 alkyl, arylcarboxamidoC1-6 alkyl, aroyl, aroylC1-6 alkyl, arylC1-6 alkanoyl, or a group CONR7R8 or SO2NR7R8, wherein R7 and R8 independently represent hydrogen or C1-6 alkyl or R7 and R8 together with the nitrogen atom to which they are attached may form a nitrogen containing heterocyclyl or heteroaryl group.
8 more elements
(canceled)
Dependencies are inferred from the claim text.